China's Pharma Companies Shift Attention to R&D Projects
China's Pharma Companies Shift Attention to R&D Projects
Attachment: China pharma R&D 0721
BEIJING--July 15, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--The China Pharmaceutical Industrial Information Centre recently released its "Top 100" ranking of pharmaceutical companies across China, as measured by "main business income." Most of the companies are state-owned entities that entered the market earlier. But pharma companies across China are transforming rapidly, with many investing heavily in research and development (R&D).
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects